A Medical Device Daily

SonoSite, (Bothell, Washington) reported that it has completed the acquisition of CardioDynamics (San Diego) a leader in impedance cardiography (ICG) for noninvasive hemodynamic assessment. Under the terms of the agreement, CardioDynamics will become a wholly-owned subsidiary of SonoSite, and CardioDynamics shareholders will receive $1.35 per share in cash. The aggregate transaction is valued at approximately $10 million, or $12.3 million net of cash and debt. Shareholders of CardioDynamics approved the acquisition on Aug. 11.

CardioDynamics' ICG product line provides non-invasive assessment of cardiac output and other hemodynamic parameters in the physician's office, outpatient clinic or hospital. The company's latest generation product, the BioZ Dx system, integrates ICG with electrocardiography (ECG), providing the ability to assess both mechanical and electrical cardiovascular function.